Rydex Series Trust Biotechnology Fund

Scorecard
4 / 5 Stars
Lipper
5 4 3 3 5
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A- (Buy)

Fund Fees

Updated 09.30.2013

Maximum Sales Fees %
Initial
Deferred

Updated 09.30.2013

Maximum Fees %
Administrative 0.25
Management 0.85
Redemption

Updated 09.30.2013

Actual Fees %
12b-1
Management 0.85
Net Expense Ratio: Annual Report 1.35
Net Expense Ratio: Prospectus 1.35

Updated 03.05.2014

Total Cost Projections
3-Year $428.00
5-Year $739.00
10-Year $1,624.00

Purchase Information

Updated 08.01.2013

Minimum Investments
Initial $2,500.00
Additional $0.00
Initial IRA $1,000.00
Additional IRA $0.00
Initial AIP
Additional AIP